---
name: Simon Hollingsworth
image: hollingsworth.jpg
job: UK Executive Director, Oncology Innovative Medicines & Early Development, AstraZeneca
---
Professor Simon Hollingsworth is Executive Director, Stratified Medicines Studies in Innovative Medicines Oncology at AstraZeneca.  He has over 20 years of experience in drug and therapeutics development, in both academia and industry, across oncology, inflammation and vascular fields. His research is focused in the fields of clinical science, personalised healthcare, companion diagnostics, clinical biomarkers and translational medicine. At AstraZeneca, he is currently responsible for the development and implementation of standardised quality patient screening modalities in basket and stratified studies, to support the successful delivery of oncology medicines.